Medication study for stomach ulcer healing after ESD
Treatments studied
Part of Cancer, Digestive system clinical trials.
This trial tests two medications, esomeprazole and sucralfate, to see if they help heal stomach ulcers after an endoscopic procedure (ESD) for early stomach cancer or pre-cancerous growths. It may help you if you need this procedure and have a larger ulcer afterwards.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 80 years old
- You have early stomach cancer or a high-grade pre-cancerous growth that will be removed with ESD
- Your lesion is in the main part of the stomach, not near the esophagus
- The doctor is able to remove the entire lesion in one piece during ESD
- Your ulcer after ESD will be at least 2 centimeters wide
- You can attend follow-up visits and have repeat endoscopies
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study looks at early stomach cancer treated with ESD, a procedure to remove the tumor through the stomach lining, and how the depth of the scar relates to healing. It may help doctors predict better outcomes and improve the procedure for suitable patients.
This trial tests a new medication (DWP14012) for people with stomach (gastric) ulcers. It aims to see if the drug helps ulcers heal better than a placebo.
This study compares two medications—vonorasan and esomeprazole—to see which one heals stomach ulcers better after a specific type of endoscopic surgery. The goal is to find the safest and most effective way to help your ulcer recover.
This trial tests a technique called full-time RDI during ESD (a minimally invasive procedure to remove early stomach cancer). The goal is to see if it can lower the chance of serious side effects and shorten the procedure time. If you are scheduled for this surgery and meet the health requirements, you may be able to join.
This study tests a new way to perform ESD, a minimally invasive procedure to remove early-stage cancers or polyps from the digestive tract. The goal is to see if this new method is safer and more effective than the standard approach.
This trial tests a medication (esomeprazole) given through an IV to help protect the stomach lining after surgery. It is for patients in the intensive care unit (ICU) for at least 3 days.
Hear when a new Early Gastric Cancer trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.